Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Alpha Amino Acid Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112279743B details a novel iridium-catalyzed asymmetric hydrogenation method for chiral alpha-amino acid esters, offering high enantioselectivity and industrial scalability for pharmaceutical intermediates.
Novel Ni-catalyzed asymmetric synthesis offers high yield and enantioselectivity for pharmaceutical intermediates, ensuring supply chain stability.
Novel Ni-catalyzed asymmetric method for chiral quaternary carbon alpha-amino acid esters. High yield, excellent ee, scalable process for API intermediates.